QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 294 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 2.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,303,000 | +39.3% | 24,903 | -2.2% | 0.14% | +29.8% |
| Q1 2014 | $1,653,000 | +11.8% | 25,459 | -6.3% | 0.10% | +9.5% |
| Q4 2013 | $1,479,000 | -0.8% | 27,171 | +5.7% | 0.10% | -11.2% |
| Q3 2013 | $1,491,000 | +1.9% | 25,705 | -20.2% | 0.11% | -3.6% |
| Q2 2013 | $1,463,000 | – | 32,196 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 2,251,660 | $146,200,000 | 28.53% |
| Palo Alto Investors LP | 1,938,990 | $125,898,000 | 5.20% |
| Valiant Capital Management, L.P. | 599,100 | $38,900,000 | 4.77% |
| Espalier Global Management LLC | 1,284,800 | $83,422,000 | 4.66% |
| CAPITAL MANAGEMENT CORP /VA | 178,365 | $11,581,000 | 3.95% |
| Freestone Capital Holdings, LLC | 303,127 | $19,682,000 | 3.49% |
| RIVULET CAPITAL, LLC | 58,000 | $3,766,000 | 3.41% |
| Formidable Asset Management, LLC | 52,640 | $4,161,000 | 2.91% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,039,865 | $67,518,000 | 2.76% |
| GROESBECK INVESTMENT MANAGEMENT CORP /NJ/ | 89,561 | $5,815,000 | 2.62% |